Rising interest rates, sky-high inflation, and geopolitical turmoil have all conspired against U.S. stock markets this year. Despite a bear market rally over the past seven weeks, every major U.S. stock exchange is still down big for the year.
For instance, the S&P 500 is currently in the red by 13%, while the Dow Jones Industrial Average has shed nearly 10% of its value, and the Nasdaq Composite is underwater by a hefty 20% for the year.
This unrelenting bear market hasn't ensnared every equity, however. Shares of Rhythm Pharmaceuticals (NASDAQ: RYTM) , SIGA Technologies (NASDAQ: SIGA) , and Veru (NASDAQ: VERU) have all blasted higher in 2022. Here's why this trio of healthcare stocks have been able to defy the 2022 bear market.
For further details see:
What Bear Market? These 3 Stocks Have Been Rocketing Higher in 2022